FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W67206502> ?p ?o ?g. }

• W67206502 abstract "OBJECTIVE: The objective of this selective EBM review is to determine whether or not, “Is Afrin (Oxymetazoline) a safe and effective drug in normal, healthy adults with reference to nasal congestion and the nasal response?” STUDY DESIGN: Review of three English language primary studies published in 1997, 1999, 2003. DATA SOURCES: Randomized, controlled studies (double-blind, placebo-controlled) testing the efficacy and safeness of Afrin in comparison to a placebo group, were found using the PubMed database. OUTCOMES MEASURED: Nasal patency, congestion, degree of nasal blockage, and symptoms (quantity, consistency, color of nasal secretions, turbinate size/color) were measured through patient diary card symptom scores, visual analogue scales, and clinical nasal visual examinations. RESULTS: The Morris et al and Watanabe et al studies found that the subjective measurements and nasal examinations did not show clinically significant signs of rhinitis or differences between treatment groups after using Afrin. A clinically significant decongestant effect of Afrin was noted at each visit in all three RCT’s. Bickford et al reports that symptoms of congestion decreased significantly after using Afrin but not after using the placebo. Morris et al and Watanabe et al found no signs of increased tolerance to Afrin, but evidence of rebound nasal congestion was reported after 3 days of Afrin treatment in the Morris study and no significant rebound nasal congestion was discovered by Watanabe et al after 4 weeks treatment. CONCLUSIONS: All three RCT’s showed that Afrin is effective in treating nasal congestion in normal, healthy adults. After subjects were treated with various doses of Afrin nasal spray, no clinically significant nasal congestion was found in any of the treatment groups. Morris et al and Watanabe et al found that there was no tolerance to the medication after using repeated doses. However, Morris et al found rebound nasal congestion after 3 days of use, whereas Watanabe et al found no rebound congestion after using various doses of Afrin for 4 weeks. Further research is needed to determine the appropriate length of treatment and possible side effects (rebound congestion) of Afrin." @default.
• W67206502 created "2016-06-24" @default.
• W67206502 creator A5066869523 @default.
• W67206502 date "2012-01-01" @default.
• W67206502 modified "2023-09-26" @default.
• W67206502 title "Is Afrin (Oxymetazoline) A Safe And Effective Drug In Normal, Healthy Adults With Reference To Nasal Congestion And The Nasal Response?" @default.
• W67206502 cites W1512058707 @default.
• W67206502 cites W1990936416 @default.
• W67206502 cites W2159928247 @default.
• W67206502 cites W2227757951 @default.
• W67206502 hasPublicationYear "2012" @default.
• W67206502 type Work @default.
• W67206502 sameAs 67206502 @default.
• W67206502 citedByCount "0" @default.
• W67206502 crossrefType "journal-article" @default.
• W67206502 hasAuthorship W67206502A5066869523 @default.
• W67206502 hasConcept C126322002 @default.
• W67206502 hasConcept C141071460 @default.
• W67206502 hasConcept C142724271 @default.
• W67206502 hasConcept C168563851 @default.
• W67206502 hasConcept C170493617 @default.
• W67206502 hasConcept C204787440 @default.
• W67206502 hasConcept C27081682 @default.
• W67206502 hasConcept C2776880894 @default.
• W67206502 hasConcept C2777844070 @default.
• W67206502 hasConcept C2778311950 @default.
• W67206502 hasConcept C2778385066 @default.
• W67206502 hasConcept C2778801703 @default.
• W67206502 hasConcept C2780042274 @default.
• W67206502 hasConcept C2910477827 @default.
• W67206502 hasConcept C40465926 @default.
• W67206502 hasConcept C42219234 @default.
• W67206502 hasConcept C71924100 @default.
• W67206502 hasConceptScore W67206502C126322002 @default.
• W67206502 hasConceptScore W67206502C141071460 @default.
• W67206502 hasConceptScore W67206502C142724271 @default.
• W67206502 hasConceptScore W67206502C168563851 @default.
• W67206502 hasConceptScore W67206502C170493617 @default.
• W67206502 hasConceptScore W67206502C204787440 @default.
• W67206502 hasConceptScore W67206502C27081682 @default.
• W67206502 hasConceptScore W67206502C2776880894 @default.
• W67206502 hasConceptScore W67206502C2777844070 @default.
• W67206502 hasConceptScore W67206502C2778311950 @default.
• W67206502 hasConceptScore W67206502C2778385066 @default.
• W67206502 hasConceptScore W67206502C2778801703 @default.
• W67206502 hasConceptScore W67206502C2780042274 @default.
• W67206502 hasConceptScore W67206502C2910477827 @default.
• W67206502 hasConceptScore W67206502C40465926 @default.
• W67206502 hasConceptScore W67206502C42219234 @default.
• W67206502 hasConceptScore W67206502C71924100 @default.
• W67206502 hasLocation W672065021 @default.
• W67206502 hasOpenAccess W67206502 @default.
• W67206502 hasPrimaryLocation W672065021 @default.
• W67206502 hasRelatedWork W117805473 @default.
• W67206502 hasRelatedWork W157786967 @default.
• W67206502 hasRelatedWork W1996050708 @default.
• W67206502 hasRelatedWork W2053025163 @default.
• W67206502 hasRelatedWork W2056073139 @default.
• W67206502 hasRelatedWork W2132992131 @default.
• W67206502 hasRelatedWork W2192358455 @default.
• W67206502 hasRelatedWork W2335007448 @default.
• W67206502 hasRelatedWork W2418805283 @default.
• W67206502 hasRelatedWork W2463280011 @default.
• W67206502 hasRelatedWork W2753728413 @default.
• W67206502 hasRelatedWork W2793233337 @default.
• W67206502 hasRelatedWork W2796203354 @default.
• W67206502 hasRelatedWork W2902605291 @default.
• W67206502 hasRelatedWork W2949442105 @default.
• W67206502 hasRelatedWork W3128596175 @default.
• W67206502 hasRelatedWork W3129435861 @default.
• W67206502 hasRelatedWork W39762267 @default.
• W67206502 hasRelatedWork W59349657 @default.
• W67206502 hasRelatedWork W653770029 @default.
• W67206502 isParatext "false" @default.
• W67206502 isRetracted "false" @default.
• W67206502 magId "67206502" @default.
• W67206502 workType "article" @default.